Markus Mezger

2.1k total citations
64 papers, 1.3k citations indexed

About

Markus Mezger is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Markus Mezger has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 21 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Markus Mezger's work include CRISPR and Genetic Engineering (15 papers), CAR-T cell therapy research (10 papers) and Immune Cell Function and Interaction (10 papers). Markus Mezger is often cited by papers focused on CRISPR and Genetic Engineering (15 papers), CAR-T cell therapy research (10 papers) and Immune Cell Function and Interaction (10 papers). Markus Mezger collaborates with scholars based in Germany, Switzerland and United States. Markus Mezger's co-authors include Rupert Handgretinger, Hermann Einsele, Juergen Loeffler, Justin S. Antony, Oliver Kurzai, Peter Lang, Susanne Kneitz, Alexander Nyström, Leena Bruckner‐Tuderman and Tobias Kühl and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Markus Mezger

61 papers receiving 1.3k citations

Peers

Markus Mezger
Christian Knabenhans Switzerland
R. Paul Johnson United States
Rafael A. Larocca United States
Xianfang Wu United States
Michael W. Melkus United States
A. Amadori Italy
Michael D. Kramer Germany
Harald G. Foellmer United States
Annalisa Kunkl Italy
Seema R. Patel United States
Christian Knabenhans Switzerland
Markus Mezger
Citations per year, relative to Markus Mezger Markus Mezger (= 1×) peers Christian Knabenhans

Countries citing papers authored by Markus Mezger

Since Specialization
Citations

This map shows the geographic impact of Markus Mezger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Mezger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Mezger more than expected).

Fields of papers citing papers by Markus Mezger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Mezger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Mezger. The network helps show where Markus Mezger may publish in the future.

Co-authorship network of co-authors of Markus Mezger

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Mezger. A scholar is included among the top collaborators of Markus Mezger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Mezger. Markus Mezger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Muralidharan, Arumugam Ramachandran, et al.. (2023). A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo. Frontiers in Pharmacology. 14. 1096614–1096614. 11 indexed citations
3.
Kim, Miso, et al.. (2023). CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells. International Journal of Molecular Sciences. 24(22). 16065–16065. 9 indexed citations
4.
Antony, Justin S., et al.. (2023). CRISPR medicine for blood disorders: Progress and challenges in delivery. SHILAP Revista de lepidopterología. 4. 1037290–1037290. 8 indexed citations
5.
6.
Schilbach, Karin, Derya Güngör, Elke Malenke, et al.. (2021). Somatic Reversion of a Novel IL2RG Mutation Resulting in Atypical X-Linked Combined Immunodeficiency. Genes. 13(1). 35–35. 8 indexed citations
7.
Döring, Michaela, Friederike Gieseke, Annika Erbacher, et al.. (2021). Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host Disease. Stem Cells and Development. 30(5). 234–246. 6 indexed citations
8.
Antony, Justin S., Jun-Hoe Lee, Lukas Heumos, et al.. (2021). A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy. The CRISPR Journal. 5(1). 66–79. 11 indexed citations
9.
Epting, Thomas, Sabina Marciano, Lukas Heumos, et al.. (2021). Universal Gene Correction Approaches for β-hemoglobinopathies Using CRISPR-Cas9 and Adeno-Associated Virus Serotype 6 Donor Templates. The CRISPR Journal. 4(2). 207–222. 6 indexed citations
10.
Döring, Michaela, Torsten Kluba, Ilias Tsiflikas, et al.. (2020). Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or Chemotherapy. Stem Cells and Development. 29(13). 811–822. 8 indexed citations
11.
Haque, A.K.M. Ashiqul, et al.. (2020). RNA ImmunoGenic Assay: Simple method for detecting immunogenicity of in vitro transcribed mRNA. 3(2). 2 indexed citations
12.
Ebinger, Martin, Ulrike Hartmann, Manon Queudeville, et al.. (2019). <p>Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies</p>. Drug Design Development and Therapy. Volume 13. 3439–3451. 6 indexed citations
13.
Mezger, Markus, Martin Schaller, Ingo Müller, et al.. (2017). Bone Marrow-Derived Stem Cells Migrate into Intraepidermal Skin Defects of a Desmoglein-3 Knockout Mouse Model but Preserve their Mesodermal Differentiation. Journal of Investigative Dermatology. 138(5). 1157–1165. 7 indexed citations
14.
Kühl, Tobias, Markus Mezger, Ingrid Haußer, et al.. (2015). High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa. Molecular Therapy. 23(8). 1368–1379. 65 indexed citations
15.
Mezger, Markus, Martin Bornhäuser, Rudolf Trenschel, et al.. (2014). KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts. Annals of Hematology. 93(9). 1579–1586. 28 indexed citations
16.
Grube, Matthias, Juergen Loeffler, Markus Mezger, et al.. (2013). TLR5 stop codon polymorphism is associated with invasive aspergillosis after allogeneic stem cell transplantation. Medical Mycology. 51(8). 818–825. 29 indexed citations
17.
Mezger, Markus, et al.. (2011). 40‐O ‐[2‐Hydroxyethyl]rapamycin modulates human dendritic cell function during exposure to Aspergillus fumigatus. Journal of Basic Microbiology. 52(3). 269–276. 4 indexed citations
18.
Loeffler, Juergen, et al.. (2010). Genetic Polymorphisms in the Cytokine and Chemokine System: Their Possible Importance in Allogeneic Stem Cell Transplantation. Current topics in microbiology and immunology. 341. 83–96. 25 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Knabenhans Breakdown of academic impact, for papers by R. Paul Johnson Breakdown of academic impact, for papers by Rafael A. Larocca Breakdown of academic impact, for papers by Xianfang Wu Breakdown of academic impact, for papers by Michael W. Melkus Breakdown of academic impact, for papers by A. Amadori Breakdown of academic impact, for papers by Michael D. Kramer Breakdown of academic impact, for papers by Harald G. Foellmer Breakdown of academic impact, for papers by Annalisa Kunkl Breakdown of academic impact, for papers by Seema R. Patel
Rankless by CCL
2026